Loading AKTS charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading AKTS comparable companies…
| AKTSAktis Oncology, Inc.(opens in a new tab) | $0.88B | — | — | — | — | — | — |
|---|---|---|---|---|---|---|---|
| TLPHTalphera, Inc.(opens in a new tab) | — | $0.00B | −96.3% | −486.2% | −1474700.0% | — | — |
| ATOSAtossa Therapeutics, Inc.(opens in a new tab) | $0.02B | $0.00B | −35.2% | −93026.9% | — | — | — |
| TCRTAlaunos Therapeutics, Inc.(opens in a new tab) | $0.00B | $0.00B | −50.0% | — | −135266.7% | 1617.08× | — |
| RLMDRelmada Therapeutics, Inc.(opens in a new tab) | $0.40B | — | — | — | — | — | — |
| Medianpeers, excl. AKTS | $0.02B | $0.00B | −50.0% | −46756.6% | −804983.3% | 1617.08× | — |